Login / Signup

One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?

Renato Francesco Maria ScaliseClaudio MontaltoMarco Valgimigli
Published in: European heart journal (2023)
Keyphrases
  • antiplatelet therapy
  • end stage renal disease
  • percutaneous coronary intervention
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • atrial fibrillation
  • peritoneal dialysis
  • patient reported